chr19-43997169-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_198089.3(ZNF155):c.1312G>A(p.Val438Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000277 in 1,614,038 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_198089.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ZNF155 | NM_198089.3 | c.1312G>A | p.Val438Ile | missense_variant | 5/5 | ENST00000270014.7 | |
ZNF230-DT | NR_110727.1 | n.1943C>T | non_coding_transcript_exon_variant | 3/3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ZNF155 | ENST00000270014.7 | c.1312G>A | p.Val438Ile | missense_variant | 5/5 | 1 | NM_198089.3 | P2 | |
ZNF230-DT | ENST00000586860.1 | n.2277C>T | non_coding_transcript_exon_variant | 2/2 | 2 |
Frequencies
GnomAD3 genomes AF: 0.000158 AC: 24AN: 152168Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000128 AC: 32AN: 250928Hom.: 0 AF XY: 0.000147 AC XY: 20AN XY: 135812
GnomAD4 exome AF: 0.000289 AC: 423AN: 1461870Hom.: 0 Cov.: 79 AF XY: 0.000264 AC XY: 192AN XY: 727242
GnomAD4 genome AF: 0.000158 AC: 24AN: 152168Hom.: 0 Cov.: 32 AF XY: 0.000161 AC XY: 12AN XY: 74328
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 10, 2022 | The c.1312G>A (p.V438I) alteration is located in exon 5 (coding exon 4) of the ZNF155 gene. This alteration results from a G to A substitution at nucleotide position 1312, causing the valine (V) at amino acid position 438 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at